Asias Currencies Under Pressure as Oil Prices Surge and US Dollar Strengthens Amid Iran Tensions BP Sacks Chairman Manifold as Leadership Turmoil Deepens at Energy Giant Quantum Computing Stocks Surge as US Government Unveils 2 Billion Funding and Equity Initiative Navigating CDs in Hospice A Familys Estate Planning Question AI Industry Emerges as Key Beneficiary of HighProfile MuskAltman Legal Proceedings Consumer Sentiment Plunges to Record Low in May as Iran Conflict Intensifies Inflation Fears CLLS Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue East West Bancorp Inc EWBC Q1 2026 Earnings EPS Beats Estimates Stock Holds Steady RMCF Q1 2026 Earnings Loss per Share Narrows as Stock Gains 415 Amplitech Group Inc AMPGZ Q1 2026 Earnings EPS Miss and Steep Stock Decline Highlight Ongoing Challenges ARRY Q1 2026 Earnings Earnings Surge Past Estimates Despite Revenue Uncertainty FMC Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment Old National Bancorp Preferred Shares ONBPO Hold Steady Near Support Levels KKRS KKR Subordinated Notes Holds Near 1631 as Low Volatility Persists Support and Resistance Levels in Focus Data IO Corporation DAIO Navigates Technical Crossroads After Modest Decline Putnam Premier Income Trust PPT Holds Steady Near Support as Yield Investors Eye Resilience Nektar Therapeutics NKTR Slips 128 as Shares Approach Key Support Level Trumps Beijing Visit Absence of Disaster Seen as Modest Progress for USChina Trade Relations PCRX Q1 2026 Earnings EPS Beat in a Quiet Quarter Rekor Systems REKR Holds at 077 as Minor Decline Tests Support Levels Kratos Defense KTOS Surges 1377 as Defense Sector Momentum Builds Xcel Energy XEL Gains Ground Near Key Support as Utilities Sector Shows Resilience Algoma Steel Group ASTL Holds Steady at 473 as Traders Eye Key Resistance and Support Levels KinderCare Learning KLC Drops 35 as Shares Test Support Zone Popular Inc BPOP Edges Higher Key Levels in Focus Eagle Point Credit Company ECC Gains Ground as Shares Test Resistance Inovio Pharmaceuticals Slips Below 130 as Selling Pressure Intensifies